Cargando…

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

Towards the end of 2019, a novel coronavirus (CoV) named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), genetically similar to severe acute respiratory syndrome coronavirus (SARS-CoV), emerged in Wuhan, Hubei province of China, and has been responsible for coronavirus disease 2019 (CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jun-Gyu, Oladunni, Fatai S., Chiem, Kevin, Ye, Chengjin, Pipenbrink, Michael, Moran, Thomas, Walter, Mark R., Kobie, James, Martinez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554492/ https://www.ncbi.nlm.nih.gov/pubmed/33068703 http://dx.doi.org/10.1016/j.jviromet.2020.113995

Ejemplares similares

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
por: Oladunni, Fatai S., et al.
Publicado: (2021)

A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
por: Piepenbrink, Michael S., et al.
Publicado: (2021)

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
por: Ye, Chengjin, et al.
Publicado: (2020)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
por: Chiem, Kevin, et al.
Publicado: (2022)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
por: Piepenbrink, Michael, et al.
Publicado: (2023)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Khalil, Ahmed M., et al.
Publicado: (2023)

A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
por: Park, Jun-Gyu, et al.
Publicado: (2020)

Antiviral neutralizing antibodies: from in vitro to in vivo activity
por: Burton, Dennis R.
Publicado: (2023)

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023)

Equine Influenza Virus and Vaccines
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
por: Piepenbrink, Michael S., et al.
Publicado: (2022)

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
por: Martinez-Sobrido, Luis, et al.
Publicado: (2023)

A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies
por: Lupitha, Santhik Subhasingh, et al.
Publicado: (2022)

Neutralizing antiviral antibody responses
por: Zinkernagel, Rolf M., et al.
Publicado: (2001)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Development of a Novel Chikungunya Virus-Like Replicon Particle for Rapid Quantification and Screening of Neutralizing Antibodies and Antivirals
por: Lin, Hui-Chung, et al.
Publicado: (2023)

Rapid AAV-Neutralizing Antibody Determination with a Cell-Binding Assay
por: Guo, Ping, et al.
Publicado: (2018)

A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients
por: Shan, Chao, et al.
Publicado: (2017)

In-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers
por: Ma, Hong-Wei, et al.
Publicado: (2017)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
por: Chen, Pan, et al.
Publicado: (2016)

Development and Evaluation of a Rapid Neutralizing Antibody Assay for COVID-19 Vaccination
por: Yu, Heshan, et al.
Publicado: (2022)

Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds
por: Schmitz, Katharina S., et al.
Publicado: (2022)

Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
por: Zarkoob, Hoda, et al.
Publicado: (2021)

Bi-Reporter Vaccinia Virus for Tracking Viral Infections In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

A Recombinant Genotype I Japanese Encephalitis Virus Expressing a Gaussia Luciferase Gene for Antiviral Drug Screening Assay and Neutralizing Antibodies Detection
por: Li, Chenxi, et al.
Publicado: (2022)

An Efficient and Rapid Assay for Detecting Neutralizing Antibodies Against Serotype 4 Fowl Adenovirus
por: Guo, Yiwen, et al.
Publicado: (2022)

Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
por: Whiting, Gail, et al.
Publicado: (2012)

Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection
por: Bonifacio, Maria Addolorata, et al.
Publicado: (2022)

Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials
por: Guerrero-Arguero, Israel, et al.
Publicado: (2023)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
por: Kim, Sun Jin, et al.
Publicado: (2022)

Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus
por: Viswanathan, Thiruselvam, et al.
Publicado: (2020)

A Review of the Phytochemistry, Ethnobotany, Toxicology, and Pharmacological Potentials of Crescentia cujete L. (Bignoniaceae)
por: Balogun, Fatai Oladunni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g6490seouh8uhp06i6paq3knni